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ABSTRACT 
Objectives 
To establish the accuracy of emergency department (ED) nursing staff risk-assessment, 
using an established chest pain risk score alone and when incorporated with presentation 
high-sensitivity troponin testing as part of an accelerated diagnostic protocol (ADP).   
 
Design 
Prospective observational study comparing nursing and physician risk-assessment using the  
modified Goldman (m-Goldman) score and a pre-defined ADP, incorporating presentation 
high-sensitivity troponin.   
Setting 
A U.K. District ED. 
Patients 
Consecutive patients, aged ≥18, with suspected cardiac chest pain and non-ischaemic ECG, 
for whom the treating physician determined serial troponin testing was required. 
Outcome Measures 
30 day major adverse cardiac events (MACE). 
Results 
960 participants were recruited. 912/960 (95.0%) had m-Goldman scores recorded by 
physicians and 745/960 (77.6%) by nursing staff.  The AUC of the m-Goldman score in 
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predicting 30 day MACE was 0.647 (95% CI 0.594-0.700) for physicians and 0.572 (95% CI 
0.510-0.634) for nursing staff (P=0.09). When incorporated into an ADP, sensitivity for the 
rule-out of MACE was 99.2% (95% CI 94.8-100) and 96.7% (90.3-99.2) for physicians and 
nurses respectively. One patient in the physician group (0.3%), and three patients (1.1%) in 
the nursing group were classified as low-risk yet had MACE..  There was fair agreement in 
the identification of low-risk patients (kappa 0.31, 95% CI 0.24-0.38). 
 
Conclusion 
The diagnostic accuracy of ED nursing staff risk-assessment is similar to that of ED physicians 
and inter-observer reliability between assessor groups is fair.  When incorporating high-
sensitivity troponin testing, a nurse-led ADP has a miss-rate of 1.1% for MACE at 30 days. 
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What is already known on this subject?  Few studies have investigated the role of nursing 
staff in the assessment of low-risk patients with chest pain.  Advanced nursing interventions 
during initial patient assessment have been proven to reduce time to treatment and 
diagnosis, improve patient flow through the ED and reduce length of stay across a wide 
variety of emergency presentations.  Nursing staff may therefore be an underutilized 
resource in mitigating crowding.   
What this study adds?  This prospective, single-centre observational study demonstrates 
that emergency department nursing staff risk assessment, using an established chest pain 
risk score is similar to that of emergency department physicians.  When combining nursing 
risk-stratification with presentation high-sensitivity troponin testing, a nurse-led accelerated 
discharge protocol would have a miss-rate of 1.1% for MACE at 30 days. This finding, 
together with fair inter-observer reliability of nursing and physician assessments in the 
identification of low-risk patients, suggests the future role of nursing staff in rapid rule-out 
pathways holds promise.    
Keywords 
Nursing 
Chest Pain 
Acute Coronary Syndrome 
Emergency Department 
Sensitivity and Specificity 
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INTRODUCTION 
 
Chest pain is one of the most common complaints of patients presenting to the emergency 
department (ED), with approximately one million visits per year in the UK.  The majority of 
patients require prolonged assessment prior to safe discharge despite the fact that only 15-
25% of these patients have a final diagnosis of acute coronary syndrome (ACS).[1]  Recently, 
accelerated diagnostic protocols (ADPs) have successfully incorporated chest pain risk 
scores with early biomarker testing to identify those patients at low-risk of major adverse 
cardiac events (MACE) who may be suitable for early discharge.[2-6]   
 
Advanced nursing interventions during initial patient assessment have been proven to 
reduce time to treatment and diagnosis, improve patient flow through the ED and reduce 
length of stay across a wide variety of emergency presentations.[7]  It is also evident that 
chest pain-specific risk scores, such as a modified TIMI score,[8] can improve the accuracy of 
nursing assessments.[9]  Yet, the ability of ED nursing staff to safely risk-stratify low-risk 
patients with suspected ACS who may be suitable for early rule-out biomarker testing and 
therefore early discharge has never been investigated.  Consequently, ED nursing staff 
remain a potentially underused resource in the assessment of chest pain.        
 
This study aimed to establish the diagnostic accuracy of ED nursing staff risk assessment, 
using an established chest pain risk score (modified Goldman) alone and when incorporated 
with presentation high-sensitivity troponin testing as part of a nurse-led accelerated 
6 
 
diagnostic protocol.  The secondary aim was to evaluate the inter-observer reliability of 
nursing and physician assessments within the modified Goldman risk score.  
METHODS 
This prospective observational clinical trial was designed to assess the pre-defined Triage 
Rule-out Using high-Sensitivity Troponin (TRUST) ADP.  This ADP incorporates a non-
ischaemic ECG, a modified Goldman (m-Goldman) risk score,[10] and a single presentation 
high-sensitivity troponin (hs-cTnT) result (Table 1).  The study protocol was designed to be 
truly pragmatic in order to enhance the widespread applicability of the study results:[11] 
treating ED physicians and nursing staff performed m-Goldman risk scores, real-time sample 
processing and 24/7 recruitment.  Results from physician assessment using the TRUST ADP 
have been published previously.[6]  The study was designed using the Standards for 
Reporting Diagnostic Accuracy (STARD),[12] and approved by the U.K. National Research 
Ethics Service.  All patient participants and nursing staff provided written informed consent.  
The TRUST study was registered with the Controlled Trials Database (ISRCTN No. 21109279).  
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Table 1. The Modified Goldman Score and the TRUST ADP 
MODIFIED GOLDMAN RISK SCORE 1 point for each variable present  
Typical new onset chest pain at rest  
Pain the same as previous myocardial infarction  
Pain not relieved by Glyceryl Trinitrate (GTN) 
Spray within 15 minutes 
 
Pain lasting more than 60 minutes  
Pain occurring with increasing frequency  
Hypotension (Systolic Blood Pressure 
<100mmHg) 
 
Acute shortness of breath  
Pain within 6 weeks of a myocardial infarction or 
revascularisation 
 
Modified Goldman Total:  
TRUST ACCELERATED DIAGNOSTIC PROTOCOL 
(TRUST ADP) 
 
Low risk* 
(Suitable for discharge) 
1. Modified Goldman Score ≤1 
2. Non-ischaemic ECG 
3. Presentation high-sensitivity 
troponin T <14ng/L 
Not Low Risk 
 
1. Modified Goldman Score >1 
2. Ischaemic ECG 
3. Presentation high-sensitivity 
troponin T ≥14ng/L 
*Safety Point:  Protocol not validated in age ≥80 years 
 
Study Setting, Recruitment and Data Collection 
Poole NHS Foundation Trust is a U.K. District General, the ED has approximately 62 000 new 
patient attendances per year.  Patients with suspected ACS are managed according to the 
local hospital protocol, which involves risk assessment by ED physician staff using the m-
Goldman risk score and blood drawn for hs-cTnT at 6 hours after presentation.  As part of 
the study protocol, blood was also taken at presentation for hs-cTnT analysis. Whilst 
historical clinical protocols, at the time of this study, did not include troponin measurement 
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at presentation, this had the benefit of ensuring that treating physicians were blinded to the 
initial hs-cTnT result to avoid selection bias and observation bias.[13]   
 
The fifth generation Roche ELECSYS hs-cTnT assay (Roche, Switzerland) which has a 99th 
percentile of 14ng/L and 10% coefficient of variation of <10% at 9ng/L, was used for both 
presentation and reference (6-hour) samples.  During initial assessment clinical staff drew 
blood for routine admission samples and an additional 3.5mls of whole blood in a pre-
labelled study specific serum settling tube for hs-cTnT analysis.  All serum samples were 
tested in real time. 
 
Consecutive patients attending the ED with suspected ACS were prospectively screened 
from July 2012 to August 2013.    Patients were included if they were ≥18 years of age and 
had at least 5 minutes of chest pain suggestive of ACS, and for whom the treating physician 
determined inpatient evaluation was required.  No patient was observed within the ED to 
await 6-hour blood draws, due to the UK national healthcare target that patients must be 
seen, treated, admitted or discharged within 4 hours.  Possible cardiac symptoms included 
acute chest, epigastric, neck, jaw or arm pain, or discomfort or pressure without an 
apparent non-cardiac source, in accordance with the American Heart Association case 
definitions.[14]  Patients were excluded if any of the following were present: STEMI or left 
bundle branch block not known to be old, ECG changes diagnostic of ischaemia (ST segment 
depression ≥1mm or T-wave inversion consistent with the presence of ischaemia), 
arrhythmias (new-onset atrial fibrillation, atrial flutter, sustained supraventricular 
tachycardia, second-degree or complete heart block, or sustained or recurrent ventricular 
arrhythmias), hs-cTnT not suitable for analysis (e.g. haemolysis), age ≥80 years, atypical 
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symptoms in the absence of chest discomfort, a clear non-ACS cause for chest pain was 
found at presentation (e.g. pulmonary embolism, pneumonia, aortic dissection), another 
medical condition requiring hospital admission, refusal or inability to give informed consent, 
non-English speaking, pregnancy, renal failure requiring dialysis or inability to be contacted 
after discharge.    
 
ED physician staff undertook initial ECG evaluation as part of clinical care, later confirmed by 
two local cardiologists (nursing staff were not expected to undertake ECG evaluation).  
Patients with ECG evidence of acute myocardial infarction or acute ischaemia were 
immediately defined as high risk in accordance with Goldman’s original rule and therefore 
not recruited. 
 
Data were collected prospectively using a published data dictionary.[15]  ED nursing staff 
undertaking initial assessment were asked to record the m-Goldman risk score on a case 
report form, at the time of patient presentation to the ED.  Nursing staff were experienced 
in the primary assessment and triage of ED patients with chest pain but had no formal 
training in the use of the m-Goldman score.  Consequently they were provided with written 
explanatory notes on how to complete the risk score.  The nursing risk score was kept 
separate from the clinical notes in a colored envelope and removed by a member of the 
research team at the earliest opportunity.  Attending ED physicians completed an identical 
m-Goldman risk score as part of routine clinical assessment on a separate clinical 
assessment form.   
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Follow-up was undertaken by independent review of hospital electronic patient records, 
summary of health records from the patient’s General Practitioner (GP) obtained at least 6-
months after attendance and a national clinical records search (which identifies death).  
Where a participant had not attended hospital follow-up and/or a GP had failed to provide a 
health record/not GP-registered, the patient was regarded as lost to follow-up. 
 
Index Tests 
The index test was the m-Goldman score evaluated by both physicians and ED nursing staff. 
In order to establish the potential diagnostic accuracy of the m-Goldman score within a 
nurse-led ADP, the secondary index test of the TRUST ADP was used.  This defined a patient 
as 'low-risk’ if all of the following conditions were satisfied at presentation:  An m-Goldman 
Score of ≤1 (Table 1), a non-ischaemic ECG and a single central laboratory hs-cTnT of 
<14ng/L.  
 
Outcome Measures 
The endpoint was the presence of major adverse cardiac events (MACE) occurring within 30 
days of hospital attendance (including the index visit).  MACE included: death due to 
ischaemic heart disease, cardiac arrest, symptom-induced revascularisation, cardiogenic 
shock, ventricular arrhythmia, high-degree atrioventricular block needing intervention and 
acute myocardial infarction (AMI).  This definition is consistent with previous large scale 
research analyzing the diagnostic accuracy of ADPs.[3]     
The presence of AMI was defined according to the Third Universal Definition of MI which 
states that a rise and/or fall in troponin, with at least one value above the 99th centile value 
in the context of a patient with ischaemic symptoms or signs (ECG changes or imaging 
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evidence) would satisfy the diagnosis.[16]  Based on current consensus guidance for high-
sensitivity troponin assays, a rise or fall of 20% (delta) was considered statistically significant 
and consistent with a diagnosis of AMI.[17]  Adjudication of the primary endpoint was 
carried out by two local cardiologists blinded to the nursing m-Goldman score but whom 
had access to the clinical record, ECG and serial hs-cTnT results.  
Statistical Analysis 
Chi-squared analyses were used to generate 2 x 2 tables for the calculation of sensitivity, 
specificity, and positive and negative likelihood ratios.  Receiver-operating characteristic 
curves were generated from sensitivity and specificity to give an overall summary of 
diagnostic accuracy.  Significance was calculated using the Fisher’s exact test for 
contingency tables and Mann-Whitney U test for non-parametric data; all reported p-values 
are two-tailed.  Inter-observer reliability was assessed using Cohen’s kappa.    Statistical 
analysis was carried out using SPSS version 20.  
 
RESULTS 
Of 1096 eligible patients, 964 were recruited; 4 patients were lost to follow-up meaning that 
99.6% were successfully monitored for 30 days.  132 patients were eligible, but not 
recruited due to missing the consent process, these were similar in age, gender and risk 
factors (P>0.05 for all).  124/960 patients (12.5%) had the outcome event MACE within 30 
days.  Figure 1 is a STARD diagram depicting a participant recruitment flow chart according 
to physician and nursing assessments.  912/960 (95.0%) had m-Goldman scores recorded by 
ED physicians and 745/960 (77.6%) by nursing staff.   
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There were no significant differences between physician and nursing patient-groups in age, 
gender, risk factors for coronary artery disease, prior cardiovascular history and hospital 
length of stay (P>0.05 for all) (Table 2).   
 
Table 2.  Patient Demographics 
 Physician 
Assessed 
(n=912) 
Nursing 
Assessed 
(n=745) 
Significance of the 
difference between 
Physician and Nursing 
groups 
Age, years: Mean (SD) 58.0 (13.3) 58.0 (13.2) P=1.00 
Sex n male (%) 546 (59.9) 431 (57.9) P=0.41 
Ethnicity n White British (%) 869 (95.3) 714 (95.8) P=0.59 
Risk factors n (%)    
Hypertension 505 (55.4) 409 (54.9) P=0.85 
Hyperlipidaemia 601 (65.9) 488 (65.5) P=0.87 
Smoking Current 219 (24.0) 182 (24.4) P=0.84 
Diabetes 152 (16.7) 120 (16.1) P=0.76 
Family History of CAD 340 (37.3) 280 (37.6) P=0.90 
Medical History    
Angina 238 (26.1) 187 (25.1) P=0.64 
Myocardial Infarction 194 (21.3) 159 (21.3) P=0.97 
Percutaneous Coronary Intervention 173 (19.0) 133 (17.9) P=0.56 
Congestive Cardiac Failure 27 (3.0) 21 (2.8) P=0.86 
Atrial Arrhythmia 115 (12.6) 91 (12.2) P=0.81 
Stroke/TIA 62 (6.8) 50 (6.7) P=0.94 
Length of Stay: Median (IQR) 18.7 (32.3) 18.3 (25.0) P=0.82 
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Diagnostic Accuracy of Nursing Staff Risk-Assessment Using the m-Goldman Score 
Contingency tables showing the occurrence of MACE according to index tests are available 
as Online Supplementary Data.  The primary aim of the m-Goldman score is to identify low-
risk patients who may be suitable for discharge, therefore the test metric of interest is 
sensitivity (rule-out).  Table 3 demonstrates a sensitivity for the diagnosis of 30 day MACE of 
73.9% (95%CI 65.5-81.1) and 63.0% (95%CI 53.0-72.3) for physicians and nursing staff 
respectively, when using the rule-out m-Goldman cut-off of ≤1.  
Using the area under the curve (Figure 2) as an estimate of the overall diagnostic accuracy 
of the m-Goldman score in predicting 30 day MACE, there was no significant difference 
between assessor groups: 0.647 (95% CI 0.594-0.700) for physicians and 0.572 (95% CI 
0.510-0.634) for nursing staff assessments (P=0.09). 
 
Diagnostic Accuracy of the TRUST ADP 
Table 3 also presents the statistical analysis of the TRUST ADP for predicting MACE at 30 
days according to assessor groups.  One patient in the physician group (0.3%), and three 
patients (1.1%) in the nursing group were classified as low risk by the ADP yet had MACE at 
30 days.  Sensitivity of the ADP for the rule-out of MACE was 99.2% (95% CI 94.8-100) and 
96.7% (90.3-99.2) for physician and nursing groups respectively.   
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Table 3.  Diagnostic Accuracy of the m-Goldman score and the TRUST ADP for predicting MACE at 
30 days according to assessor groups. 
 
 
 
 Presentation 
hsTnT <14ng/L 
Physician m-
Goldman Score 
≤1 
Nurse m-
Goldman Score 
≤1  
Physician 
TRUST ADP 
Nurse TRUST 
ADP  
Number of 
Patients 
Assessed 
960 912 745 912 745 
Number of low 
risk patients 
with 30-day 
MACE missed 
(%) 
24/766  
(3.1) 
31/426  
(7.3) 
34/328  
(10.4) 
1/355  
(0.3) 
3/264  
(1.1) 
Sensitivity  80.6  
(73.3-86.6) 
73.9  
(65.5-81.1) 
63.0  
(53.0-72.3) 
99.2  
(94.8-100) 
96.7  
(90.3-99.2) 
Negative 
predictive value 
96.9  
(95.7-97.8) 
92.7  
(90.4-94.7) 
89.6  
(86.8-92.2) 
99.7  
(98.3-100) 
98.9  
(96.6-99.7) 
Specificity 88.8  
(87.7-89.6) 
49.8  
(48.5-50.9) 
45.0  
(43.6-46.3) 
44.6  
(44.0-44.8) 
40.0  
(39.1-40.3) 
Positive 
predictive value 
51.5  
(46.9-55.3) 
18.1  
(16.0-19.9) 
13.9  
(11.7-15.9) 
21.2  
(20.3-21.4) 
18.5  
(17.3-19.0) 
Negative 
Likelihood Ratio 
0.22  
(0.15-0.30) 
0.52  
(0.37-0.71) 
0.82  
(0.60-1.08) 
0.02  
(0.00-0.12) 
0.08  
(0.02-0.25) 
Positive 
Likelihood Ratio 
7.17  
(5.95-8.35) 
1.47  
(1.27-1.65) 
1.15  
(0.94-1.35) 
1.79  
(1.69-1.81) 
1.61  
(1.48-1.66) 
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Inter-observer reliability 
Table 4 summarizes inter-observer reliability of individual components of the m-Goldman 
score and those patients identified as low-risk (m-Goldman ≤1).  The degree of reliability 
varied with four components showing fair agreement, three showing moderate agreement 
and only one showing substantial agreement (though the finding of pain within 6 weeks of 
an AMI or revascularization was only present in 1.1% of the population).  Using the m-
Goldman score, there was fair agreement in the identification of low-risk patients between 
physicians and nursing staff (kappa 0.31, 95% CI 0.24-0.38).[18] 
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Table 4. Inter-observer reliability of the m-Goldman score 
 
Clinical Feature Proportion 
of patients 
with 
finding n 
(%) 
(Physician 
n=912) 
Proportion 
of patients 
with 
finding n 
(%) 
(Nursing 
n=745) 
Significance 
of 
difference 
Kappa 95% 
Confidence 
Interval 
Level of 
agreement 
(after 
Landis).[18] 
Typical new 
onset chest pain 
at rest 
394 (43.2) 299 (40.1) P=0.21 0.22 0.15-0.30 Fair 
Pain the same as 
previous AMI 
115 (12.6) 75 (10.1) P=0.11 0.53 0.43-0.63 Moderate 
Pain not relieved 
by Glyceryl 
Trinitrate Spray 
within 15 
minutes 
166 (18.2) 133 (18.0) P=0.85 0.54 0.46-0.62 Moderate 
Pain lasting more 
than 60 minutes 
537 (58.9) 472 (63.4) P=0.06 0.38 0.31-0.44 Fair 
Pain occurring 
with increasing 
frequency 
140 (15.4) 146 (19.6) P=0.02 0.23 0.14-0.32 Fair 
Hypotension 
(Systolic BP 
<100mmHg 
23 (2.5) 16 (2.1) P=0.62 0.43 0.22-0.64 Moderate 
Acute shortness 
of breath 
167 (18.3) 177 (23.8) P=0.007 0.26 0.18-0.34 Fair 
Pain within 6 
weeks of AMI or 
revascularization 
10 (1.1) 8 (1.1) P=0.97 0.80 0.58-1.00 Substantial 
Low-risk patients 
(m-Goldman ≤1) 
426 (46.7) 328 (44.0) P=0.28 0.31 0.24-0.38 Fair 
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DISCUSSION 
This study demonstrates that the diagnostic accuracy of ED nursing staff risk assessment, 
using an established chest pain risk score is similar to that of ED physicians.  When 
combining nursing risk-stratification with presentation high-sensitivity troponin testing, a 
nurse-led ADP would have a miss-rate of 1.1% for MACE at 30 days. This finding, together 
with fair inter-observer reliability of nursing and physician assessments in the identification 
of low-risk patients, suggests the future role of nursing staff in rapid rule-out pathways 
holds promise.    
Few studies have investigated the role of nursing staff in the assessment of low-risk patients 
with suspected ACS and this is the first to compare the assessments of physician and nursing 
staff using an ADP designed specifically to identify patients suitable for early discharge.  
Chest pain in the acute setting is traditionally triaged as a high-risk presentation,[19] 
consequently this cohort of patients are nursed in high-acuity areas, despite the fact that 
few patients (only 12.5% of our study population) have major adverse outcomes.  It has 
been established that the interventions of nursing staff are important in improving the care 
of high-risk patients with chest pain.[20] However, our results also suggest that risk 
assessment by nursing staff with a focus upon low-risk patients, may be a viable strategy 
with the potential to improve ED efficiency, through early biomarker testing and the use of 
low acuity clinical areas.    
        
This study is also important in highlighting inter-observer reliability of chest pain 
assessment, which remains under-reported in the literature.  The m-Goldman risk score 
uses elements of chest pain history to identify those patients without unstable features, it 
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therefore requires some clinical judgment and subjectivity in interpretation.   All nursing 
participants were experienced in the primary assessment of ED patients with chest pain.  
Therefore the only fair agreement between assessors may be seen as unexpected.  This 
finding will not be limited to the m-Goldman score, as other commonly used risk scores also 
incorporate elements which require clinical judgment.  Examples include the History, ECG, 
Age, Risk factors and Troponin (HEART) Score,[2] Manchester Acute Coronary Syndromes 
(MACS) rule,[4] and Vancouver chest pain rule.[5]   
The ED nursing staff who took part in our analysis were all experienced in the primary 
assessment of ED patients with chest pain, however none were trained as advanced 
practitioners and they had no formal training in the use of the m-Goldman score, other than 
written instructions provided.  Therefore, we suggest that with tailored educational 
interventions, diagnostic accuracy may be improved.  Studies investigating simple training 
interventions, such as workshops, in non-specialist ED nursing staff have consistently 
demonstrated improved correlation between physician and nurse ordering, as well as more 
accurate test interpretation.[21-23]  As such, further research is required which 
incorporates formal training in chest pain assessment for nursing staff, and focuses on the 
identification of low-risk patients who may be suitable for early discharge. 
An important limitation to this study is that we included in this analysis only patients with 
suspected ACS, as decided by the treating physician.  Therefore we can make no conclusions 
on the ability of nursing staff to identify those patients with suspected ACS from 
undifferentiated chest pain.  Current evidence here is limited, with one small study 
suggesting that nursing staff have a sensitivity approaching 90% in identifying cardiac chest 
pain.[24]   In order to avoid over-selection of patients for rapid rule-out protocols and 
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consequent adverse effects of resource use through unnecessary biomarker testing, this 
issue requires clarification. 
A further limitation to this analysis is the difference in the proportion of patients who 
underwent assessment by physicians (95.0%) compared to those assessed by nursing staff 
(77.6%).  This finding may be explained by the ethical necessity for nursing staff to provide 
written informed consent prior to study participation and the transient nature of the staff 
body during the recruitment period.  However, this finding may cause unseen bias in the 
clinical characteristics of patient groups and may mean that the study had insufficient 
power to detect a diagnostic difference that did in fact exist (a Type II statistical error).   
 
 
 
CONCLUSION 
The diagnostic accuracy of ED nursing staff risk-assessment, using an established chest pain 
risk score is similar to that of ED physicians and inter-observer reliability between assessor 
groups is fair.  When combining nursing risk-stratification with presentation high-sensitivity 
troponin testing, a nurse-led ADP would have a miss-rate of 1.1% for MACE at 30 days. 
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Figure 1.  Participant recruitment flow chart 
 
Figure 2.  Receiver operating characteristic curves of the m-Goldman score according to 
assessor groups 
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